- Home
- SELF vs ALGS Comparison
SELF vs ALGS Comparison
Compare SELF & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | ALGS |
|---|---|---|
| Founded | 1983 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 49.7M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SELF | ALGS |
|---|---|---|
| Price | $5.18 | $6.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $46.67 |
| AVG Volume (30 Days) | 26.0K | ★ 37.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $12,530,280.00 | $3,611,000.00 |
| Revenue This Year | $1.59 | N/A |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $33.87 | ★ N/A |
| Revenue Growth | ★ 2.79 | N/A |
| 52 Week Low | $4.73 | $3.76 |
| 52 Week High | $5.83 | $14.57 |
Technical Indicators
Market Signals| Indicator | SELF | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 66.58 | 42.88 |
| Support Level | $5.15 | $6.18 |
| Resistance Level | $5.19 | $8.84 |
| Average True Range (ATR) | 0.07 | 0.58 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 94.00 | 41.18 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.